<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Taba">
 <table frame="hsides" rules="groups">
  <tbody>
   <tr>
    <td align="left">Coronavirus disease 2019 (COVID-19) has a significant impact on the cardiovascular (CV) system, both directly and indirectly.</td>
   </tr>
   <tr>
    <td align="left">COVID-19 infection utilizes the angiotensin-converting enzyme 2 receptor for entry into the cell</td>
   </tr>
   <tr>
    <td align="left">Infection can cause several CV syndromes, including myocardial damage, acute coronary syndrome, and arrhythmia.</td>
   </tr>
   <tr>
    <td align="left">COVID-19 can result in hypercoagulability, resulting in venous thromboembolism and pulmonary embolism, with consequent right ventricular dysfunction or failure.</td>
   </tr>
   <tr>
    <td align="left">Clinicians should also be aware of the CV effects of drugs used for COVID-19 treatment.</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
